Syneron Candela, a global aesthetic device company, has acquired Ellipse, a Danish medical device company that manufactures and markets Intense Pulsed Light (IPL) and laser-based platforms for a wide variety of medical and aesthetic skin treatments.
Ellipse's key products include Nordlys, a multi-application, multi-technology IPL and Nd:YAG platform for vascular and pigmented lesions, as well as hair removal. The Nordlys also offers a fractionated 1550nm handpiece for skin resurfacing. Other products include an IPL-only system used for skin rejuvenation, facial veins and hair removal, and a fractional nonablative laser system used for skin resurfacing. Ellipse's Selective Waveband Technology (SWT) utilizes dual filtering on all IPL handpieces to selectively deliver precise energy to the targeted area.
“The acquisition of Ellipse allows Syneron Candela to strengthen its footprint in the multi-application space and provide our customers a comprehensive portfolio,” said Geoffrey Crouse, CEO of Syneron Candela. “Ellipse platforms will provide aesthetic practices with a fully scalable multi-application, multi-technology device. We look forward to Ellipse strengthening our portfolio as we continue to deliver our brand promise of ‘Science, Results, Trust’ to our physicians and patients worldwide.”
